Back to List View Graph View

Nuclear factor erythroid 2-related factor 2 (NRF2)

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that plays a critical role in cellular defense against oxidative stress and inflammation.

Where the papers sit

42 papers from the last 6 months study Nuclear factor erythroid 2-related factor 2 (NRF2) directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 1 human data · 40 preclinical · 1 unclassified

Themes 4 themes · 1 new direction

  • KEAP1-NRF2 Therapeutics

    KEAP1-NRF2 protein-protein interaction inhibitors are emerging as direct therapeutic tools for oxidative, inflammatory and neurodegenerative disease. GSK3227634, compound 4-95 and natural-product modulators aim to activate NRF2 without relying on nonspecific antioxidant treatment. Recurrent endpoints include reduced ferroptosis, improved wound or vascular repair, and protection from neuronal injury. In cancer, however, hyperactivated NRF2 can oppose cisplatin or other stress-based treatments, keeping therapeutic selectivity unresolved.

    14 papers · 33.3%

  • Oxidative Stress and Inflammation

    NRF2/HO-1 activation is repeatedly paired with reduced oxidative injury, ferroptosis and inflammatory signalling across neural, vascular, reproductive and glandular damage. Candidate interventions include crocin, sulfonamide-flavonoids, rosmarinic acid, daphnetin, itaconate and engineered delivery platforms. Benefits are commonly linked to GPX4 preservation or suppression of NF-κB, NLRP3 and microglial activation. The work remains predominantly preclinical, with tissue repair and functional recovery rather than a single disease endpoint driving evaluation.

    12 papers · 28.6%

  • Ferroptosis and Redox Injury

    NRF2 activation is generally being used to limit ferroptosis by restoring glutathione, GPX4 and mitochondrial function. Acteoside, fumarate derivatives and ammonium tetrathiomolybdate exemplify protective strategies against metabolic, toxic and inflammatory injury. In cancer, pyrazolone compounds and p-coumaric acid instead promote ROS accumulation by suppressing NRF2-linked defenses. The central question is when redox activation protects tissue and when disabling it can selectively kill tumour cells.

    8 papers · 19%

  • NRF2 in Metabolic Liver Disease

    Metabolic liver research is moving from generic antioxidant protection toward cholesterol sensing, VLDL secretion and selective NRF2 target activation in MASLD and MASH. The NFE2L1-INSIG1 axis and KEAP1-NRF2 signalling frame lipid handling as a driver of disease progression and graft quality. Epigenetic dysregulation, including m6A and compensatory arginine methylation, is linked to premalignant change. Related brain and aging studies extend the question to sex-dependent metabolic stress, mitochondrial dysfunction and ferroptosis.

    8 papers · 19%

NEW DIRECTION

In pancreatic cancer, tumor-intrinsic NRF2 hyperactivation creates rather than prevents vulnerability to CAR T-cell therapy

Pancreatic ductal adenocarcinoma treated with CAR T cells was assumed to be limited by tumor-intrinsic stress adaptation, with NRF2 functioning as a protective stress-response pathway; instead, genetic KEAP1 ablation or clinically observed KEAP1/NFE2L2 mutations that hyperactivate NRF2 increased tumor susceptibility to CAR T-cell killing in immunocompetent orthotopic models 42826199Oct. This assigns NRF2 a role outside the set's usual cytoprotective, antioxidant, and therapy-resistance categories: a tumor-cell state that can enhance immune-cell-mediated elimination and potentially serve as a biomarker for CAR T-cell response.

Papers

The 42 papers from the last 6 months that study Nuclear factor erythroid 2-related factor 2 (NRF2) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

KEAP1-NRF2 Therapeutics (14)
  1. Integrated network pharmacology, transcriptomics, and molecular simulations reveal polydatin protects against aortic dissection associated with PPARγ/Nrf2-related antioxidant signaling. Biochemical and biophysical research communications · 16 Oct 2026 PMID 42887389
  2. Tumor cell-intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer. Science advances · 2 Oct 2026 PMID 42826199
  3. Effect of Lactiplantibacillus plantarum SCS6 on pancreatic oxidative damage in mice with type 2 diabetes based on gut-pancreas axis. Antonie van Leeuwenhoek · 15 Sept 2026 PMID 42742757
  4. SIRT6 restrains hyperactivated Nrf2 to enhance cisplatin response in lung cancer models. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727479
  5. A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720490
  6. The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein-Protein Interaction for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720473
  7. Neuroprotective Effects of Cistanoside A against Cadmium-induced Neurotoxicity via Keap1/Nrf2/NF-kB Signaling: In Vivo and In Silico approaches. Molecular neurobiology · 1 Sept 2026 PMID 42678483
  8. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  9. Integrated In Silico Discovery of Thymoquinone Analogs Targeting the Keap1-Nrf2 Pathway for Amyotrophic Lateral Sclerosis Therapy. ChemistryOpen · 19 Aug 2026 PMID 42613775
  10. Cross-Kingdom miR5054 Delivery via Polygonum cuspidatum-Derived Nanoparticles Enhances Burn Wound Healing by Regulating Microvascular Environment. ACS nano · 18 Aug 2026 PMID 42611244
  11. Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes. Endocrinology, diabetes & metabolism · 10 Aug 2026 PMID 42573124
  12. XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma. Cell chemical biology · 7 Jul 2026 PMID 42413506
  13. Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis. European journal of medicinal chemistry · 2 Jul 2026 PMID 42391929
  14. A Keap1-Nrf2 protein-protein interaction inhibitor 4-95 ameliorates cognitive dysfunction by suppressing neuronal ferroptosis. Bioorganic chemistry · 20 Jun 2026 PMID 42322910
Oxidative Stress and Inflammation (12)
  1. 4-Octyl Itaconate Attenuates Age-Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 30 Sept 2026 PMID 42811753
  2. Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation. Molecular neurobiology · 5 Sept 2026 PMID 42700283
  3. Curcumin exerts distinct anti-tumor effects mediated by NRF1α from NRF2 via metabolic reprogramming in hepatocellular carcinoma (HepG2). Bioorganic chemistry · 20 Aug 2026 PMID 42623915
  4. MTA does not induce oxidative stress and apoptotic response, or calcium-related cellular stress and preserves extracellular matrix homeostasis. Molecular biology reports · 24 Jul 2026 PMID 42496770
  5. Nano-Rosmarinic Acid Protects Against Chlorfenapyr-Induced Testicular Toxicity Through Modulation of NRF2/HO-1 and NF-κB/NLRP3 Signaling Pathways. Journal of biochemical and molecular toxicology · 21 Jul 2026 PMID 42478942
  6. Wireless Magnetoelectric Stimulation Platform Orchestrating Multicellular Coupling in Complex Neurovascularized Tissue Regeneration. ACS nano · 20 Jul 2026 PMID 42473233
  7. Anti-bacterial layer coated Zn-doped mesoporous silica drug-carry platform for infected wound healing by inhibiting ferroptosis via the AMPK/Nrf2 axis. Biochemical and biophysical research communications · 14 Jul 2026 PMID 42447551
  8. Sulfonamide-flavonoid analogue SG16 shows promise as a novel anti-inflammatory agent for ischemic stroke treatment. Bioorganic chemistry · 25 Jun 2026 PMID 42348941
  9. MCL inhibits macrophage ferroptosis through the NRF2/HO-1/GPX4 axis to attenuate carotid atherosclerotic plaque formation. International immunopharmacology · 22 Jun 2026 PMID 42330582
  10. Daphnetin alleviates neuropathic pain in rats by modulating spinal microglial polarization via the Nrf2/NLRP3 inflammasome pathway. International immunopharmacology · 17 Jun 2026 PMID 42308799
  11. Trichostatin A-primed spinal cord organoids alleviate oxidative stress and improve recovery after spinal cord injury involving the NRF2/HO-1 signaling pathway. Neuroscience · 6 Jun 2026 PMID 42250855
  12. Mechanistic investigation of the ameliorative effect of crocin on arsenic trioxide-induced HT22 nerve cells injury based on network pharmacology and in vitro validation. Neuroscience · 22 May 2026 PMID 42173304
Ferroptosis and Redox Injury (8)
  1. Emodin ameliorates diabetic cardiomyopathy by regulating mitochondrial dynamics of fission and fusion and ferroptosis through the AHR-Nrf2 pathway. International journal of molecular medicine · 6 Nov 2026 PMID 42992574
  2. p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation. Medical oncology (Northwood, London, England) · 10 Sept 2026 PMID 42720830
  3. Acteoside alleviates high glucose-induced ROS accumulation and ferroptosis in ARPE-19 cells by activating the NRF2 signaling pathway. Molecular biology reports · 9 Sept 2026 PMID 42714715
  4. Ammonium tetrathiomolybdate improves auditory and vestibular function after gentamicin exposure via the NRF2-GPX4 axis. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Sept 2026 PMID 42687382
  5. Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression. Cellular and molecular neurobiology · 20 Jul 2026 PMID 42474538
  6. Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. ACS chemical neuroscience · 7 Jul 2026 PMID 42412905
  7. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
  8. Connecting a Western diet, palmitic acid, and enteric neuropathy. The Journal of clinical investigation · 1 Jun 2026 PMID 42222886
NRF2 in Metabolic Liver Disease (8)
  1. Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy. Free radical biology & medicine · 20 Oct 2026 PMID 42901279
  2. Sex-based differences in the gut-metabolism axis in aging and Nrf2-deficient mice. PloS one · 21 Sept 2026 PMID 42766607
  3. Tert-Butylhydroquinone Reversed Age-Dependent Hypothalamic Mitochondrial Dysfunction Linking Maternal Fructose Exposure to Synaptic Vulnerability. Molecular neurobiology · 16 Sept 2026 PMID 42749864
  4. Dysregulated m6A via compensatory arginine methylation primes premalignancy in metabolic dysfunction-associated steatotic liver disease. Science advances · 9 Sept 2026 PMID 42715338
  5. HMGB1 aggravates neuronal ferroptosis and microglial inflammation in metabolic syndrome-associated cognitive impairment via the NRF2-autophagic flux axis. Molecular biomedicine · 18 Aug 2026 PMID 42608631
  6. Cholesterol-responsive NFE2L1-INSIG1 interaction controls VLDL secretion and metabolic dysfunction-associated steatohepatitis pathogenesis in mice. The Journal of clinical investigation · 15 Jul 2026 PMID 42454498
  7. Targeting hepatic cholesterol sensing to tackle metabolic dysfunction-associated steatohepatitis. The Journal of clinical investigation · 15 Jul 2026 PMID 42454495
  8. Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690

By study type

Human data, design not indexed (1)
  1. Integrated In Silico Discovery of Thymoquinone Analogs Targeting the Keap1-Nrf2 Pathway for Amyotrophic Lateral Sclerosis Therapy. ChemistryOpen · 19 Aug 2026 PMID 42613775
Preclinical: animal, cell and lab studies (40)
  1. Emodin ameliorates diabetic cardiomyopathy by regulating mitochondrial dynamics of fission and fusion and ferroptosis through the AHR-Nrf2 pathway. International journal of molecular medicine · 6 Nov 2026 PMID 42992574
  2. Integrated network pharmacology, transcriptomics, and molecular simulations reveal polydatin protects against aortic dissection associated with PPARγ/Nrf2-related antioxidant signaling. Biochemical and biophysical research communications · 16 Oct 2026 PMID 42887389
  3. Tumor cell-intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer. Science advances · 2 Oct 2026 PMID 42826199
  4. 4-Octyl Itaconate Attenuates Age-Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 30 Sept 2026 PMID 42811753
  5. Sex-based differences in the gut-metabolism axis in aging and Nrf2-deficient mice. PloS one · 21 Sept 2026 PMID 42766607
  6. Tert-Butylhydroquinone Reversed Age-Dependent Hypothalamic Mitochondrial Dysfunction Linking Maternal Fructose Exposure to Synaptic Vulnerability. Molecular neurobiology · 16 Sept 2026 PMID 42749864
  7. Effect of Lactiplantibacillus plantarum SCS6 on pancreatic oxidative damage in mice with type 2 diabetes based on gut-pancreas axis. Antonie van Leeuwenhoek · 15 Sept 2026 PMID 42742757
  8. SIRT6 restrains hyperactivated Nrf2 to enhance cisplatin response in lung cancer models. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727479
  9. p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation. Medical oncology (Northwood, London, England) · 10 Sept 2026 PMID 42720830
  10. A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720490
  11. The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein-Protein Interaction for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720473
  12. Dysregulated m6A via compensatory arginine methylation primes premalignancy in metabolic dysfunction-associated steatotic liver disease. Science advances · 9 Sept 2026 PMID 42715338
  13. Acteoside alleviates high glucose-induced ROS accumulation and ferroptosis in ARPE-19 cells by activating the NRF2 signaling pathway. Molecular biology reports · 9 Sept 2026 PMID 42714715
  14. Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation. Molecular neurobiology · 5 Sept 2026 PMID 42700283
  15. Ammonium tetrathiomolybdate improves auditory and vestibular function after gentamicin exposure via the NRF2-GPX4 axis. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Sept 2026 PMID 42687382
  16. Neuroprotective Effects of Cistanoside A against Cadmium-induced Neurotoxicity via Keap1/Nrf2/NF-kB Signaling: In Vivo and In Silico approaches. Molecular neurobiology · 1 Sept 2026 PMID 42678483
  17. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  18. Curcumin exerts distinct anti-tumor effects mediated by NRF1α from NRF2 via metabolic reprogramming in hepatocellular carcinoma (HepG2). Bioorganic chemistry · 20 Aug 2026 PMID 42623915
  19. Cross-Kingdom miR5054 Delivery via Polygonum cuspidatum-Derived Nanoparticles Enhances Burn Wound Healing by Regulating Microvascular Environment. ACS nano · 18 Aug 2026 PMID 42611244
  20. HMGB1 aggravates neuronal ferroptosis and microglial inflammation in metabolic syndrome-associated cognitive impairment via the NRF2-autophagic flux axis. Molecular biomedicine · 18 Aug 2026 PMID 42608631
  21. Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes. Endocrinology, diabetes & metabolism · 10 Aug 2026 PMID 42573124
  22. MTA does not induce oxidative stress and apoptotic response, or calcium-related cellular stress and preserves extracellular matrix homeostasis. Molecular biology reports · 24 Jul 2026 PMID 42496770
  23. Nano-Rosmarinic Acid Protects Against Chlorfenapyr-Induced Testicular Toxicity Through Modulation of NRF2/HO-1 and NF-κB/NLRP3 Signaling Pathways. Journal of biochemical and molecular toxicology · 21 Jul 2026 PMID 42478942
  24. Monomethyl Fumarate Modulates Iron Metabolism and Mitochondrial Function in Microglia with Implications for Multiple Sclerosis Progression. Cellular and molecular neurobiology · 20 Jul 2026 PMID 42474538
  25. Wireless Magnetoelectric Stimulation Platform Orchestrating Multicellular Coupling in Complex Neurovascularized Tissue Regeneration. ACS nano · 20 Jul 2026 PMID 42473233
  26. Cholesterol-responsive NFE2L1-INSIG1 interaction controls VLDL secretion and metabolic dysfunction-associated steatohepatitis pathogenesis in mice. The Journal of clinical investigation · 15 Jul 2026 PMID 42454498
  27. Targeting hepatic cholesterol sensing to tackle metabolic dysfunction-associated steatohepatitis. The Journal of clinical investigation · 15 Jul 2026 PMID 42454495
  28. Anti-bacterial layer coated Zn-doped mesoporous silica drug-carry platform for infected wound healing by inhibiting ferroptosis via the AMPK/Nrf2 axis. Biochemical and biophysical research communications · 14 Jul 2026 PMID 42447551
  29. XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma. Cell chemical biology · 7 Jul 2026 PMID 42413506
  30. Structure-Property Relationship Analysis of α-Keto Ester Prodrugs of Monomethyl Fumarate as NRF2 Activators. ACS chemical neuroscience · 7 Jul 2026 PMID 42412905
  31. Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis. European journal of medicinal chemistry · 2 Jul 2026 PMID 42391929
  32. Sulfonamide-flavonoid analogue SG16 shows promise as a novel anti-inflammatory agent for ischemic stroke treatment. Bioorganic chemistry · 25 Jun 2026 PMID 42348941
  33. Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690
  34. MCL inhibits macrophage ferroptosis through the NRF2/HO-1/GPX4 axis to attenuate carotid atherosclerotic plaque formation. International immunopharmacology · 22 Jun 2026 PMID 42330582
  35. A Keap1-Nrf2 protein-protein interaction inhibitor 4-95 ameliorates cognitive dysfunction by suppressing neuronal ferroptosis. Bioorganic chemistry · 20 Jun 2026 PMID 42322910
  36. Daphnetin alleviates neuropathic pain in rats by modulating spinal microglial polarization via the Nrf2/NLRP3 inflammasome pathway. International immunopharmacology · 17 Jun 2026 PMID 42308799
  37. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
  38. Trichostatin A-primed spinal cord organoids alleviate oxidative stress and improve recovery after spinal cord injury involving the NRF2/HO-1 signaling pathway. Neuroscience · 6 Jun 2026 PMID 42250855
  39. Connecting a Western diet, palmitic acid, and enteric neuropathy. The Journal of clinical investigation · 1 Jun 2026 PMID 42222886
  40. Mechanistic investigation of the ameliorative effect of crocin on arsenic trioxide-induced HT22 nerve cells injury based on network pharmacology and in vitro validation. Neuroscience · 22 May 2026 PMID 42173304
Unclassified: not yet indexed with MeSH (1)
  1. Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy. Free radical biology & medicine · 20 Oct 2026 PMID 42901279